Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagu...
Saved in:
Published in | Thrombosis and haemostasis Vol. 102; no. 5; p. 936 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.11.2009
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagulant activity in plasma samples. The objective of this study was to distinguish the effects of assay conditions [tissue factor (TF), thrombomodulin, platelets/lipids] and factor levels on thrombin generation parameters, and determine the conditions and parameters with the highest sensitivity and specificity for detecting elevated factor levels. Thrombin generation was measured using calibrated automated thrombography (CAT) in corn trypsin inhibitor (CTI)-treated platelet-free plasma (PFP) and platelet-rich plasma (PRP). Statistical analysis was performed using logarithms of observed values with analysis of variance that accounted for experiment and treatment. The relative sensitivity of lag time (LT), time to peak (TTP), peak height and endogenous thrombin potential (ETP) to elevated factors XI, IX, VIII, X, and prothrombin was as follows: PFP initiated with 1 pM TF > PFP initiated with 5 pM TF > PRP initiated with 1 pM TF. For all conditions, inclusion of thrombomodulin prolonged the LT and decreased the peak and ETP; however, addition of thrombomodulin did not increase the ability of CAT to detect elevated levels of individual procoagulant factors. In conclusion, CAT conditions differentially affected the sensitivity of thrombin generation to elevated factor levels. Monitoring the peak height and/or ETP following initiation of clotting in PFP with 1 pM TF was most likely to detect hypercoagulability due to increased procoagulant factor levels. |
---|---|
AbstractList | Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagulant activity in plasma samples. The objective of this study was to distinguish the effects of assay conditions [tissue factor (TF), thrombomodulin, platelets/lipids] and factor levels on thrombin generation parameters, and determine the conditions and parameters with the highest sensitivity and specificity for detecting elevated factor levels. Thrombin generation was measured using calibrated automated thrombography (CAT) in corn trypsin inhibitor (CTI)-treated platelet-free plasma (PFP) and platelet-rich plasma (PRP). Statistical analysis was performed using logarithms of observed values with analysis of variance that accounted for experiment and treatment. The relative sensitivity of lag time (LT), time to peak (TTP), peak height and endogenous thrombin potential (ETP) to elevated factors XI, IX, VIII, X, and prothrombin was as follows: PFP initiated with 1 pM TF > PFP initiated with 5 pM TF > PRP initiated with 1 pM TF. For all conditions, inclusion of thrombomodulin prolonged the LT and decreased the peak and ETP; however, addition of thrombomodulin did not increase the ability of CAT to detect elevated levels of individual procoagulant factors. In conclusion, CAT conditions differentially affected the sensitivity of thrombin generation to elevated factor levels. Monitoring the peak height and/or ETP following initiation of clotting in PFP with 1 pM TF was most likely to detect hypercoagulability due to increased procoagulant factor levels. |
Author | Machlus, Kellie R Wolberg, Alisa S Wu, Jogin R Key, Nigel S Colby, Emily A Koch, Gary G |
Author_xml | – sequence: 1 givenname: Kellie R surname: Machlus fullname: Machlus, Kellie R organization: Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA – sequence: 2 givenname: Emily A surname: Colby fullname: Colby, Emily A – sequence: 3 givenname: Jogin R surname: Wu fullname: Wu, Jogin R – sequence: 4 givenname: Gary G surname: Koch fullname: Koch, Gary G – sequence: 5 givenname: Nigel S surname: Key fullname: Key, Nigel S – sequence: 6 givenname: Alisa S surname: Wolberg fullname: Wolberg, Alisa S |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19888532$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kMtKAzEUhoMoWqs715IHcDSXaSZZSqlWKLip4K7kclIDM0nJZASfwZd2rOPqP3z8FziX6DSmCAjdUHJPqSAP2zVRFeEVoZKcoBlbiKYSUr2fowuqpJQLzmboe-U92NLj5HEJfT8A9tqWlO9w-cipM6lLbmhDxDo6DC186gIO2zaVEuJ-MuORQzuWxCk1-vcQIesSRhZ-MWCr22DyMa-HkrrjNa3ss-6u0JnXbQ_Xk87R29Nqu1xXm9fnl-XjprKSklIpqgUBq-rGEmsba0xtHeHgRE1ZrShnRrqmtoY6IiinUjjNlKyNAGK48GyObv96D4PpwO0OOXQ6f-3-v8J-AJcnZIM |
CitedBy_id | crossref_primary_10_1016_j_thromres_2021_01_012 crossref_primary_10_1016_j_jtha_2023_03_024 crossref_primary_10_1111_bjh_13641 crossref_primary_10_1186_s41983_021_00275_7 crossref_primary_10_1016_j_thromres_2011_04_009 crossref_primary_10_1160_TH12_05_0355 crossref_primary_10_1309_AJCPC5C4AGFRDKMX crossref_primary_10_1160_TH12_07_0529 crossref_primary_10_1074_jbc_M114_550566 crossref_primary_10_1097_MBC_0000000000000390 crossref_primary_10_1016_j_saa_2021_120250 crossref_primary_10_1016_j_bpj_2018_11_009 crossref_primary_10_1016_j_thromres_2014_02_002 crossref_primary_10_1111_jth_14744 crossref_primary_10_1161_ATVBAHA_117_309794 crossref_primary_10_1186_s12959_021_00335_1 crossref_primary_10_1111_jth_12600 crossref_primary_10_1089_ten_teb_2013_0709 crossref_primary_10_1111_j_1538_7836_2010_03825_x crossref_primary_10_1111_jth_14581 crossref_primary_10_1016_j_thromres_2016_05_018 crossref_primary_10_3390_jcm10153401 crossref_primary_10_1038_nrdp_2015_6 crossref_primary_10_1111_j_1365_2141_2012_09134_x crossref_primary_10_1097_ALN_0000000000000540 crossref_primary_10_1182_blood_2011_06_362814 crossref_primary_10_1111_ijlh_12293 crossref_primary_10_1016_j_thromres_2016_01_027 crossref_primary_10_1080_00914037_2024_2376247 crossref_primary_10_1182_blood_2010_11_316885 crossref_primary_10_1182_bloodadvances_2020003968 crossref_primary_10_1093_toxsci_kfu071 crossref_primary_10_1002_rth2_12310 crossref_primary_10_25557_0031_2991_2017_03_63_68 crossref_primary_10_1007_s12288_019_01092_y crossref_primary_10_1093_humrep_det092 crossref_primary_10_1016_j_thromres_2020_07_053 crossref_primary_10_1007_s12185_022_03528_0 crossref_primary_10_1016_j_thromres_2016_09_024 crossref_primary_10_1016_j_rpth_2024_102636 crossref_primary_10_1213_ANE_0b013e31823a088c crossref_primary_10_1016_j_cca_2014_12_020 crossref_primary_10_1080_00365513_2018_1427280 crossref_primary_10_5482_HAMO_16_09_0034 crossref_primary_10_1097_MBC_0000000000001148 crossref_primary_10_1161_ATVBAHA_112_250332 crossref_primary_10_1016_j_thromres_2010_09_002 crossref_primary_10_1016_j_thromres_2010_10_017 crossref_primary_10_1111_vox_12420 crossref_primary_10_1111_j_1365_2516_2010_02253_x crossref_primary_10_1371_journal_pone_0124448 crossref_primary_10_1111_jth_12707 crossref_primary_10_1182_blood_2009_06_228940 crossref_primary_10_1016_j_thromres_2019_04_033 crossref_primary_10_1080_16078454_2022_2043573 crossref_primary_10_1016_j_thromres_2015_04_020 crossref_primary_10_1097_EJA_0000000000000322 crossref_primary_10_1007_s11239_019_01894_x crossref_primary_10_1161_ATVBAHA_110_221721 crossref_primary_10_1161_ATVBAHA_113_301607 crossref_primary_10_3390_jcm9103077 crossref_primary_10_5482_HAMO_14_08_0033 crossref_primary_10_1016_j_bja_2019_02_012 crossref_primary_10_3899_jrheum_130200 crossref_primary_10_1111_hae_13157 crossref_primary_10_1111_jth_15270 crossref_primary_10_1213_ANE_0000000000001188 crossref_primary_10_1002_rth2_12611 crossref_primary_10_1002_rth2_12499 crossref_primary_10_1002_rth2_12332 crossref_primary_10_1002_rth2_12497 crossref_primary_10_1016_j_rpth_2024_102337 crossref_primary_10_1016_j_rpth_2023_102197 crossref_primary_10_1016_j_transci_2020_102852 crossref_primary_10_1111_j_1423_0410_2011_01562_x crossref_primary_10_1016_j_cbpc_2017_07_005 crossref_primary_10_1080_21655979_2021_1981755 crossref_primary_10_1097_ALN_0000000000001760 crossref_primary_10_3389_fcell_2022_967482 crossref_primary_10_1111_jth_12997 crossref_primary_10_1016_j_thromres_2018_10_020 crossref_primary_10_1016_j_thromres_2012_07_017 crossref_primary_10_1111_jth_14011 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1160/TH09-03-0180 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 2567-689X |
ExternalDocumentID | 19888532 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: K01 AR051021 – fundername: NIAMS NIH HHS grantid: K01AR051021 |
GroupedDBID | CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-c810t-91a60ec947c0cc7cbb4cd03ed641249132b8d74cb1d0613186da2984b6e0b36f2 |
IngestDate | Sat May 31 02:11:21 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c810t-91a60ec947c0cc7cbb4cd03ed641249132b8d74cb1d0613186da2984b6e0b36f2 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2904819 |
PMID | 19888532 |
ParticipantIDs | pubmed_primary_19888532 |
PublicationCentury | 2000 |
PublicationDate | 2009-11-01 |
PublicationDateYYYYMMDD | 2009-11-01 |
PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Thrombosis and haemostasis |
PublicationTitleAlternate | Thromb Haemost |
PublicationYear | 2009 |
Score | 2.2898161 |
Snippet | Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 936 |
SubjectTerms | Adult Automation Blood Coagulation Factors - physiology Blood Coagulation Tests Calibration Coumarins - analysis Female Fluorometry - instrumentation Fluorometry - methods Humans Male Middle Aged Oligopeptides - analysis Plasma Platelet-Rich Plasma Thrombin - biosynthesis Thrombomodulin - physiology Thromboplastin - physiology Time Factors Young Adult |
Title | Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19888532 |
Volume | 102 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELa2cOGCispfC5UP3CCQxI6THFG1dFW0iMNW6q3yb1spWVdq9sIr8DC8IjN2sklbQMAlimxnHXm-tWcm38wQ8oZJJZVmWWJr5xJuU5Yo7lRSSMll7kylHQYKL7-IxSk_OSvOZrMfE9bSplPv9bdfxpX8j1ShDeSKUbL_INntj0ID3IN84QoShutfyXg-kjG6sIB9-RxcN6x_0CrfehO45ugfx1ByiRqmbnykO8fhbxtkDvXfDfApGH8R0lFPmZAgTDSt8Xm56Xwb7vpZkOI1VXNXsRmTneDEl9K2HtTQm6utBr-U-rLZ3MTQoAYU4ZG5eOSbmO5zHnwvoyNhE939F_BC28GffaxldYzsv-NbPoy6D-YLR1DY60DxKhNRhaq648ac5hMEFpNtto5JU-5v_wL5kqsFfvBBmlgsEjVBwnUboJDVYPgX0bH65947ybiHrh2yA2YJ1ln9uhzCKUT6YTpzSEcbR98xWYLqstolj3ubg36MAHpCZna9R7734KHe0QgeGtHwjt6GDgUJ0gE6dIBOP5hG6FC_pgN06AgdeoXNlo7QoVvo0Al0npLTT_PV0SLpK3MkusrSDk5IKVKra17qVOtSK8W1SZk1IhQzz1iuKlNyrTKD-mJWCSPzuuJK2FQx4fJn5MHar-0LQg2DI6Uuq8rIjBeOqUxz5pgxBeNFyfKX5Hlcu_PrmH7lfFjV_d_2HJBHI8pekYcO_u_2NSiPnToMIvsJo7N4zA |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+tissue+factor%2C+thrombomodulin+and+elevated+clotting+factor+levels+on+thrombin+generation+in+the+calibrated+automated+thrombogram&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Machlus%2C+Kellie+R&rft.au=Colby%2C+Emily+A&rft.au=Wu%2C+Jogin+R&rft.au=Koch%2C+Gary+G&rft.date=2009-11-01&rft.eissn=2567-689X&rft.volume=102&rft.issue=5&rft.spage=936&rft_id=info:doi/10.1160%2FTH09-03-0180&rft_id=info%3Apmid%2F19888532&rft_id=info%3Apmid%2F19888532&rft.externalDocID=19888532 |